AllenLo

MNOV initiated clinical trial for ALS

Long
NASDAQ:MNOV   MediciNova, Inc.
0
With all the participant in ICE-BUCKET challenge around the globe, ALS.org did a tremendous job on started this movement in raising the awareness of Amyotrophic Lateral Sclerosis. MNOV took the opportunity and initiate clinical trial on ALS. Stock momentum is picking up, chart is currently showing bullish sign.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.